# Pharmacokinetics of Tenofovir, Emtricitabine, Maraviroc, and Raltegravir in Cervical, Vaginal, and Rectal Tissues and Secretions

> **NCT01330199** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 49 (actual)

## Conditions studied

- Healthy Adult Females

## Interventions

- **OTHER:** Pharmacokinetic Sampling

## Key facts

- **NCT ID:** NCT01330199
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01330199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01330199, "Pharmacokinetics of Tenofovir, Emtricitabine, Maraviroc, and Raltegravir in Cervical, Vaginal, and Rectal Tissues and Secretions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01330199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*